SIGN UP
LOG IN
C
01681
Consun Pharmaceutical Group
11.10
-0.14-1.25%Noon Closed11:57 06/19 HKT
OPEN/PREV CLOSE11.240/11.240
TODAY RANGE10.940-11.240
VOL1.02M
MARKET CAP9.46B
52 WEEK RANGE5.260-11.740
AVG VOL (3M)2.35M
% TURNOVER0.12%
TURNOVER11.26M
P/E (TTM)9.623
% RANGE2.67%
EPS(TTM)1.154
P/E(FORWARD)7.877
P/B2.138
BVPS5.192
DIVIDEND0.600
P/S2.953
BETA--
DIV YIELD5.41%
FREE FLOAT MKT CAP9.46B
SHARES OUTSTANDING852.32M
NEXT EARNINGS--
FREE FLOAT852.32M
LOT SIZE1000
EX-DATE06/10/2025
News
Press Releases
Financial Reports
Profile
Simply Wall St·05/21 22:45
Consun Pharmaceutical Group Insiders Added CN¥51.2m Of Stock To Their Holdings
Simply Wall St·05/04 01:03
Consun Pharmaceutical Group Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line
Simply Wall St·04/30 22:35
Is Now The Time To Put Consun Pharmaceutical Group (HKG:1681) On Your Watchlist?
Simply Wall St·04/01 04:07
Asian Market's Top Value Stock Picks For April 2025
Reuters·03/26 04:10
CONSUN PHARMACEUTICAL GROUP FY REVENUE RMB 2,970 MILLION
Simply Wall St·03/13 23:28
Insiders the biggest winners as Consun Pharmaceutical Group Limited's (HKG:1681) market cap rises to HK$6.8b
Simply Wall St·12/16/2024 23:58
Consun Pharmaceutical Group's (HKG:1681) earnings growth rate lags the 40% CAGR delivered to shareholders
Simply Wall St·11/27/2024 22:58
These 4 Measures Indicate That Consun Pharmaceutical Group (HKG:1681) Is Using Debt Safely
Simply Wall St·10/06/2024 23:05
SEHK Top 3 Dividend Stocks To Watch In October 2024
Simply Wall St·10/01/2024 22:39
Consun Pharmaceutical Group First Half 2024 Earnings: EPS: CN¥0.50 (vs CN¥0.44 in 1H 2023)
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.